Interestingly, low expression of Gal-9 was associated with significantly shorter OS (p = 0.013) and tended to be associated with poor DFS (p = 0.069) in patients with TNBC with PD-L1 negativity in tumor cells (Figure 2). This evidence concerns the gene LGALS9 and neoplasm.